News

Even if they have health insurance, some patients with rheumatoid arthritis may not be receiving adequate therapy.

In addition to killing emotions and proving to be ineffective for back pain and osteoarthritis, the most common drug ingredient in the US can also cause severe bodily harm.

The treatment window of opportunity for rheumatoid arthritis was debated in a recent editorial published in the Annals of Rheumatic Diseases.

There’s an app in development that could make it easier -- even fun-- for young children with juvenile idiopathic arthritis to describe where and how much they hurt.

This overview of NSAIDs, corticosteroids, DMRDs, PDE4 inhibitors, and biologic agents offers recommendations for first-line options for mild and moderate-to-severe psoriatic arthritis.

Ultrasound diagnosis of tenosynovitis has now been shown to be superior to clinical signs and symptoms (eg, early morning stiffness, symmetrical arthritis, and hand joint arthritis) in predicting early rheumatoid arthritis.

New guidelines issued at EULAR 2015 outline ways to reduce risks of complications for pregnant women with SLE and antiphospholipid syndrome. Details here.

Physical trauma, especially a deep trauma to bones and/or joints, appears to increase the risk of psoriatic arthritis by as much as 50% in patients with psoriasis.

A comprehensive review has compiled and summarized all current information about pathology, diagnosis, and treatment of the various subsets of myositis.

Researchers have identified a set of rules that determine which molecules can trigger immune system vulnerability to common autoimmune disorders like lupus and psoriasis.

Only 1% to 3% of patients with non-radiographic axial spondyloarthritis achieve remission or low disease activity without TNF-α blockers, but these agents are not yet approved for this use in the US.

Spicy food may hold more power than just adding a little zest to a meal. Researchers have uncovered a key interaction that is responsible for the sensations of pain and heat.

The overall cost of rheumatoid arthritis treatment has dropped over the past decade in Germany. Researchers there say several factors are driving the trend.

The FDA rightfully cracked down on compounding pharmacies under a 2013 law brought on by 64 deaths traced to contaminated drugs at a dirty compounding facility. But physicians are concerned the FDA's new powers could end in-office compounding for individual patients, a common practice in many medical specialities.

(CCR 2015) A number of new osteoporosis treatments are on the near horizon, drawing on a new understanding of bone biology, as described by a speaker at the Clinical Congress of Rheumatology.

Weight loss may have an important role in the nonpharmacologic management of obese patients with rheumatoid arthritis, a new study shows.

Calcium pyrophosphate deposition disease is many times more common than rheumatoid arthritis, but rarely studied and difficult to diagnose. Here an expert rheumatologist offers the basics for management today and prospects for the future.

A new study suggests the importance of evaluating the vitamin D3 status and screening for comorbid conditions in patients with psoriasis or psoriatic arthritis.

Physicians' total annual Medicare part B fee-for-service payment data for 2013 was released by CMS today. The American Medical Association fears a replay of last year's release when many physicians appeared, inaccurately, to be getting very rich from Medicare payments.

The "Green Berets" of the brain, microglia cells, become hyperactive in fibromyalgia and are key to causing symptoms, said a psychologist and neuroscientist. Finding ways to control them is the key to future treatments, he feels.

Patients with gout may find relief from severe inflammatory pain due to recently explored peripheral system channels.

Chronic painful conditions can have a significant negative impact on a patient's quality of life, but are some conditions worse than others? A recent study sought to determine which chronic pain condition creates the biggest burden on patient quality of life.

People with a rare inherited condition known as "congenial insensitivity to pain" (CIP), which makes it impossible for them to feel pain, may hold the answer to providing pain relief for patients suffering with chronic pain.

Patients' levels of anxiety and defensiveness are associated with how they view their chronic back pain, a new study showed.

A collaborative team from the Mayo Clinic and Cleveland Clinic recently examined the prevalence of migraines in patients with fibromyalgia. The study, presented at the 34th Annual American Pain Society Scientific Meeting in Palm Springs, CA, used patients from the Mayo Clinic Fibromyalgia Registry database.

While maintaining high levels of physical activity may not appeal to many patients with fibromyalgia (FM), doing so may be the best way to help ease their pain.

Work productivity can be improved in early rheumatoid arthritis patients using a combination etanercept and methotrexate therapy.

Erectile dysfunction (ED) may be a more common comorbidity than previously thought among patients with gout. Patients with gout may also be more likely to have severe ED.

Research shows febuxostat is more effective than allopurinol in reducing serum urate levels in patients with gout.

Bone erosions found at a rheumatoid arthritis (RA) patient’s baseline exam are harbingers of future joint damage and more severe disease. As to why this is so, new studies offer only hints.